Memapsin 2 (beta-secretase) inhibitors: drug development.
about
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsBeta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice.Meeting the unique challenges of drug discovery for neurodegenerative diseasesHarnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trialsPartial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.Capturing the essence of organic synthesis: from bioactive natural products to designed molecules in today's medicine.Cu(II)-catalyzed olefin migration and Prins cyclization: highly diastereoselective synthesis of substituted tetrahydropyrans.Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.Genetics of Alzheimer's disease: recent advances.Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo.Current concepts in Alzheimer's disease: a multidisciplinary review.The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential.Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors.Treatment strategies targeting amyloid β-protein.Effect of Cinnamomum Verum Extract on the Amyloid Formation of Hen Egg-white Lysozyme and Study of its Possible Role in Alzheimer's Disease.Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.Multiple e-Pharmacophore Modeling Combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of β-Secretase(BACE1).Dynamics of Aβ42 reduction in plasma, CSF and brain of rats treated with the γ-secretase modulator, GSM-10h.
P2860
Q26866006-B52D5E27-A625-4E16-932B-252BE242C3E1Q30497942-3228A890-10FB-4BAA-8992-0283B08A9BC5Q33469818-C85DD82D-606B-4765-84AC-429DD0615CA2Q33870886-AA7EB514-5A9A-49C2-8BFC-4B083CD4A7F1Q34014237-895393D0-63E2-4405-9604-E41DDEA74347Q34067152-D5B6B9EC-846F-427E-B9C9-360DCB80B35CQ34361292-25812882-9344-4D86-83E1-DA5D4627FFA8Q35162926-1892B496-C62B-4690-9F81-866AA2253E88Q35551497-0D4025FC-D134-4549-A8EA-B9572E44006DQ37149245-12BD475E-AD3A-4130-B343-C60F873EDF33Q37357276-BD811B56-397F-4274-8DBC-A90663A38E57Q37360292-50955381-2640-4473-85C0-4B947DFD84CAQ37614747-4DBDB8B6-4E51-400A-A91B-54879AEAF61EQ37866692-03EE39A8-4CE5-423D-AA31-854EC1047093Q38040990-26D18D77-2596-466F-9C2F-DB7BB9DD9F19Q38259182-7EBB2103-6BAA-4C04-9D33-4F76D52D4424Q38850493-F920F19C-CD92-4777-9B6C-BFC7FD8C9685Q39535413-496A53DB-2962-49D6-94A5-5DF1DBE5D598Q47581900-92F94070-1482-49F7-915D-9556FD18B817
P2860
Memapsin 2 (beta-secretase) inhibitors: drug development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Memapsin 2 (beta-secretase) inhibitors: drug development.
@en
Memapsin 2
@nl
type
label
Memapsin 2 (beta-secretase) inhibitors: drug development.
@en
Memapsin 2
@nl
prefLabel
Memapsin 2 (beta-secretase) inhibitors: drug development.
@en
Memapsin 2
@nl
P2093
P1476
Memapsin 2 (beta-secretase) inhibitors: drug development.
@en
P2093
Arun K Ghosh
Gerald Koelsh
Jordan Tang
Nagaswamy Kumaragurubaran
P304
P356
10.2174/156720508783954730
P577
2008-04-01T00:00:00Z